Current Antiplatelet Treatment Strategy in Patients with Diabetes Mellitus

Current Antiplatelet Treatment Strategy in Patients with Diabetes Mellitus

Patients with diabetes mellitus (DM) have accelerated atherosclerosis with an increased risk for atherothrombotic cardiovascular complications. A state of high platelet reactivity and activation, hypercoagulability (prothrombotic state) and a subdued response to standard antiplatelet agents may expl...

Full description

Bibliographic Details
Main Authors: Jung Hwa Jung, Udaya S. Tantry, Paul A. Gurbel, Young-Hoon Jeong
Format: Article
Language:English
Published: Korean Diabetes Association 2015-04-01
Series:Diabetes & Metabolism Journal
Subjects:
Aspirin
Atherothrombosis
Diabetes
Platelet
P2Y inhibitor
Online Access:http://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-39-95.pdf

Internet

http://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-39-95.pdf

Similar Items